IL-33 Expression Is Lower in Current Smokers at both Transcriptomic and Protein Levels

Alen Faiz(University of Technology Sydney), Maarten van den Berge(University Medical Center Groningen), Irene H. Heijink(University Medical Center Groningen), Pieter S. Hiemstra(Leiden University Medical Center), Fia Boedijono(University of Technology Sydney), Matt D. Johansen(University of Technology Sydney), Huib A.M. Kerstjens, Maria Stella de Biase(Max Delbrück Center), Simon D. Pouwels(Institute for Asthma and Allergy), Anne M. van der Does(Leiden University Medical Center), Hélène Goulaouic(Sanofi (France)), Peter Wark(John Hunter Hospital), Martijn C. Nawijn(University Medical Center Groningen), Rashad Mohammad Mahbub(University of Technology Sydney), Wim Timens(University Medical Center Groningen), Kian Fan Chung(Imperial College London), Heming Xing(AVEO Oncology (United States)), David J. Lederer(Regeneron (United States)), Ian M. Adcock(Imperial College London), Emanuele de Rinaldis(Target (United States)), Roland F. Schwarz(Helmholtz Association of German Research Centres), Sivan Harel, Philip M. Hansbro(University of Technology Sydney), Machteld N. Hylkema(University Medical Center Groningen), Corry‐Anke Brandsma(University Medical Center Groningen), Florian Massip(ParisTech), Wierd Kooistra(University Medical Center Groningen), Milan I. Tomassen(University Medical Center Groningen), Raolat M. Abdulai(Sanofi (United States)), Michael C. Nivens(Regeneron (United States)), Danen Cunoosamy(AstraZeneca (Sweden))

American Journal of Respiratory and Critical Care Medicine

September 14, 2023

Cited by 39

|American Journal of Respiratory and Critical Care Medicine|2018|4.1k

|European Respiratory Journal|2013|3.9k

|American Journal of Respiratory and Critical Care Medicine|2009|1.9k

|The Journal of Experimental Medicine|2005|1.2k

|American Journal of Respiratory and Critical Care Medicine|2020|1k

Related Papers